DE3686582D1 - Behandlung einer krankheit vom aids-typ. - Google Patents
Behandlung einer krankheit vom aids-typ.Info
- Publication number
- DE3686582D1 DE3686582D1 DE8787900438T DE3686582T DE3686582D1 DE 3686582 D1 DE3686582 D1 DE 3686582D1 DE 8787900438 T DE8787900438 T DE 8787900438T DE 3686582 T DE3686582 T DE 3686582T DE 3686582 D1 DE3686582 D1 DE 3686582D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- treating
- type disease
- aids
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80255385A | 1985-11-27 | 1985-11-27 | |
PCT/US1986/002575 WO1987003204A1 (en) | 1985-11-27 | 1986-11-25 | Treatment of aids-type disease |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3686582D1 true DE3686582D1 (de) | 1992-10-01 |
DE3686582T2 DE3686582T2 (de) | 1993-01-28 |
Family
ID=25184024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8787900438T Revoked DE3686582T2 (de) | 1985-11-27 | 1986-11-25 | Behandlung einer krankheit vom aids-typ. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4921837A (de) |
EP (1) | EP0246322B1 (de) |
JP (1) | JPH0764742B2 (de) |
AT (1) | ATE79761T1 (de) |
AU (1) | AU589731B2 (de) |
DE (1) | DE3686582T2 (de) |
WO (1) | WO1987003204A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5556620A (en) * | 1985-02-05 | 1996-09-17 | Cetus Oncology Corporation | Use of recombinant colony stimulating factor-1 to enhance wound healing |
WO1986004607A1 (en) * | 1985-02-05 | 1986-08-14 | Cetus Corporation | Recombinant colony stimulating factor-1 |
US4847201A (en) * | 1985-02-05 | 1989-07-11 | Cetus Corporation | DNA encoding for CSF-1 and accompanying recombinant systems |
US5104650A (en) * | 1985-02-05 | 1992-04-14 | Cetus Corporation | Uses of recombinant colony stimulating factor-1 |
US5837229A (en) * | 1985-02-05 | 1998-11-17 | Chiron Corporation | Uses of recombinant colony stimulating factor-1 |
US6103224A (en) * | 1985-02-05 | 2000-08-15 | Chiron Corporation | N∇2 CSF-1 (short form) and carboxy truncated fragments thereof |
US5422105A (en) * | 1985-02-05 | 1995-06-06 | Cetus Oncology Corporation | Use of recombinant colony stimulating factor 1 |
US6156300A (en) * | 1985-02-05 | 2000-12-05 | Chiron Corporation | Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof |
US5573930A (en) * | 1985-02-05 | 1996-11-12 | Cetus Oncology Corporation | DNA encoding various forms of colony stimulating factor-1 |
EP0643972B1 (de) * | 1987-09-22 | 2002-03-06 | Chiron Corporation | Verwendung von rekombinantem koloniestimulierendem Faktor-1 zur Herstellung eines Medikaments gegen Cytomegalovirusinfektionen |
US5120525A (en) * | 1988-03-29 | 1992-06-09 | Immunomedics, Inc. | Radiolabeled antibody cytotoxic therapy of cancer |
AU630637B2 (en) * | 1988-11-09 | 1992-11-05 | Schering Corporation | Treatment of myelosuppression associated with acquired immune deficiency |
US5211947A (en) * | 1988-12-16 | 1993-05-18 | Schering Corporation | Method for lowering blood cholesterol levels with granulocyte-macrophage colony stimulating factor |
WO1990008554A1 (en) * | 1989-01-30 | 1990-08-09 | Schering Corporation | Treatment of leukocyte dysfunction with gm-csf |
US5087453A (en) * | 1990-11-01 | 1992-02-11 | Otsuka Pharmaceutical Co., Ltd. | Method for the treatment of bacterial caused weight loss and/or hypoglycemia |
US5204101A (en) * | 1991-10-15 | 1993-04-20 | Stubblefield Thomas W | Method and composition for treating acquired immunodeficiency syndrome |
ITFI940106A1 (it) * | 1994-05-27 | 1995-11-27 | Menarini Ricerche Sud Spa | Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica |
US20030207813A1 (en) * | 1996-12-09 | 2003-11-06 | G.D. Searle | Retroviral protease inhibitor combinations |
US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
US6576231B2 (en) * | 1997-09-12 | 2003-06-10 | Schering Ag | Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor |
US6309632B1 (en) * | 1998-04-28 | 2001-10-30 | Immunex Corporation | Methods for treating HIV-infected patients by administering GM-CSF |
NZ512040A (en) * | 1998-11-06 | 2004-03-26 | Schering Ag | Use of GM-CSF to inhibit development of drug resistance in HIV + Patients |
DE10234192B4 (de) | 2002-07-26 | 2009-11-26 | Epoplus Gmbh Co.Kg | Verwendung von Erythropoetin |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU523077B2 (en) * | 1978-03-20 | 1982-07-08 | Green Cross Corporation, The | Hgi glycoprotein |
US4230697A (en) * | 1978-07-03 | 1980-10-28 | Morinaga Milk Industry Co. Ltd. | Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same |
JPS57149228A (en) * | 1981-03-11 | 1982-09-14 | Ajinomoto Co Inc | Novel erythropoietin and its preparation |
US4677195A (en) * | 1985-01-11 | 1987-06-30 | Genetics Institute, Inc. | Method for the purification of erythropoietin and erythropoietin compositions |
WO1986004587A1 (en) * | 1985-02-05 | 1986-08-14 | Cetus Corporation | Purification of native colony stimulating factor-1 |
CA1297003C (en) * | 1985-09-20 | 1992-03-10 | Jack H. Nunberg | Composition and method for treating animals |
JPH0618778B2 (ja) * | 1985-10-04 | 1994-03-16 | 中外製薬株式会社 | 白血球減少症治療剤 |
-
1986
- 1986-11-25 AU AU67397/87A patent/AU589731B2/en not_active Ceased
- 1986-11-25 EP EP87900438A patent/EP0246322B1/de not_active Revoked
- 1986-11-25 US US07/081,489 patent/US4921837A/en not_active Expired - Lifetime
- 1986-11-25 JP JP62500063A patent/JPH0764742B2/ja not_active Expired - Lifetime
- 1986-11-25 DE DE8787900438T patent/DE3686582T2/de not_active Revoked
- 1986-11-25 WO PCT/US1986/002575 patent/WO1987003204A1/en not_active Application Discontinuation
- 1986-11-25 AT AT87900438T patent/ATE79761T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US4921837A (en) | 1990-05-01 |
JPS63502342A (ja) | 1988-09-08 |
ATE79761T1 (de) | 1992-09-15 |
JPH0764742B2 (ja) | 1995-07-12 |
EP0246322A1 (de) | 1987-11-25 |
DE3686582T2 (de) | 1993-01-28 |
EP0246322B1 (de) | 1992-08-26 |
AU6739787A (en) | 1987-07-01 |
WO1987003204A1 (en) | 1987-06-04 |
EP0246322A4 (de) | 1989-11-07 |
AU589731B2 (en) | 1989-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3686582D1 (de) | Behandlung einer krankheit vom aids-typ. | |
ATE131068T1 (de) | Behandlung von pathologischen zuständen und krankheiten. | |
DE69008010D1 (de) | Sauerstoffdelignifizierung und enzymatische Behandlung. | |
DE3579113D1 (de) | Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden. | |
DE3587741D1 (de) | Behandlung von Hautkrankheiten. | |
DK0850068T3 (da) | Lipidekstrakt med antiinflammatorisk aktivitet | |
DE3750934D1 (de) | Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten. | |
ATE62414T1 (de) | Mittel zur behandlung von herzerkrankungen. | |
ATE79544T1 (de) | Zusammensetzungen zur behandlung von hypercholesterinaemie. | |
ATE411026T1 (de) | Mittel zur behandlung der alzheimer-krankheit | |
DE69202019D1 (de) | Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS. | |
DE3777861D1 (de) | Behandlung von gasen. | |
ES2063060T3 (es) | Benzamida contra enfermedades cognoscitivas. | |
DE3875866D1 (de) | Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie. | |
ATE148628T1 (de) | 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten | |
LV10689A (lv) | Dimetilpolisiloksana pielietojums kunga un zarnu trakta slimibu arstesanai | |
NO162557C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner. | |
DE59107536D1 (de) | Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose | |
NO307955B1 (no) | Blandinger omfattende nitrogensubstituert acridin | |
DE69127713D1 (de) | Behandlung von Abgasen, die Silikon- und/oder Phosphorverbindungen enthalten | |
DE3582935D1 (de) | Mittel zur behandlung von erkrankungen der venen und des analbereichs. | |
TR199802200A2 (xx) | S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi. | |
ATE25969T1 (de) | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten. | |
DE3674321D1 (de) | Behandlung geschmeidiger gewebe. | |
ATE70181T1 (de) | Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |